Literature DB >> 6839187

Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta.

I R Dickson, M Bagga, C R Paterson.   

Abstract

The concentration of alpha 2HS-glycoprotein was measured in the serum and urine of normal individuals and of patients with osteogenesis imperfecta. The serum concentration of alpha 2HS-glycoprotein was higher in normal children than in adults. In women values showed a progressive age-related decrease, from 632 mg/l at 21-30 years to 573 mg/l at 51-60 years. In men there was no such age-related variation, and values were higher than in women of comparable age; the mean value for men aged 20-60 years was 648 mg/l. Of 48 patients with osteogenesis imperfecta, 11 had an abnormally high concentration of alpha 2HS-glycoprotein in serum; the cause of this is not clear. In urine of 24 normal individuals the mean value of the ratio albumin: alpha 2HS-glycoprotein was 20 +/- 3; in serum the corresponding ratio was 70. Urine excretion of alpha 2HS-glycoprotein was lowest in female children (132 +/- 29 micrograms/24 h) and highest in male adults (592 +/- 91 micrograms/24 h); values in patients with osteogenesis imperfecta did not differ from normal.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839187     DOI: 10.1007/bf02405000

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

1.  Changes in the serum alpha glycoprotein distribution in trauma patients.

Authors:  C J van Oss; P M Bronson; J R Border
Journal:  J Trauma       Date:  1975-05

2.  Alpha-2-HS-glycoprotein levels of normal human plasma and urine.

Authors:  J R Poortmans; R W Jeanloz; K Schmid
Journal:  Clin Chim Acta       Date:  1967-08       Impact factor: 3.786

3.  Biochemical heterogeneity of osteogenesis imperfecta: New variant.

Authors:  A C Nicholls; F M Pope; H Schloon
Journal:  Lancet       Date:  1979-06-02       Impact factor: 79.321

4.  Localisation of plasma alpha2HS glycoprotein in mineralising human bone.

Authors:  I R Dickson; A R Poole; A Veis
Journal:  Nature       Date:  1975-07-31       Impact factor: 49.962

5.  Opsonic properties of human serum alpha-2 hs glycoprotein.

Authors:  C J van Oss; C F Gillman; P M Bronson; J R Border
Journal:  Immunol Commun       Date:  1974

6.  Scanning electron microscopy of teeth in dominant osteogenesis imperfecta: support for genetic heterogeneity.

Authors:  L S Levin; J M Brady; M Melnick
Journal:  Am J Med Genet       Date:  1980

7.  Plasma alpha 2HS-glycoprotein concentration in Paget's disease of bone: its possible significance.

Authors:  B A Ashton; R Smith
Journal:  Clin Sci (Lond)       Date:  1980-05       Impact factor: 6.124

8.  Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.

Authors:  J P Lebreton; F Joisel; J P Raoult; B Lannuzel; J P Rogez; G Humbert
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

9.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

10.  The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta.

Authors:  M J Francis; K J Williams; B C Sykes; R Smith
Journal:  Clin Sci (Lond)       Date:  1981-06       Impact factor: 6.124

View more
  11 in total

1.  Fetuin: an acute phase protein in cattle.

Authors:  K M Dziegielewska; W M Brown; C C Gould; N Matthews; J E Sedgwick; N R Saunders
Journal:  J Comp Physiol B       Date:  1992       Impact factor: 2.200

2.  Two bovine models of osteogenesis imperfecta exhibit decreased apatite crystal size.

Authors:  L W Fisher; E D Eanes; L J Denholm; B R Heywood; J D Termine
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

3.  Mineralized tissue protein profiles in the Australian form of bovine osteogenesis imperfecta.

Authors:  L W Fisher; L J Denholm; K M Conn; J D Termine
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

4.  Immunohistochemical localization of alpha 2HS glycoprotein in dentin.

Authors:  Y Takagi; H Shimokawa; M Suzuki; H Nagai; S Sasaki
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

5.  Three forms of BRP-2 (bone resorptive proteins) from human cancer ascites fluid and their relationship to human serum alpha-2 HS-glycoprotein.

Authors:  M S Lamkin; C Colclasure; M Rodrick; R F Troxler; G D Offner; W S Lloyd; K Schmid; R B Nimberg
Journal:  Calcif Tissue Int       Date:  1987-09       Impact factor: 4.333

6.  Statistical analysis of variation in the human plasma proteome.

Authors:  Todd H Corzett; Imola K Fodor; Megan W Choi; Vicki L Walsworth; Kenneth W Turteltaub; Sandra L McCutchen-Maloney; Brett A Chromy
Journal:  J Biomed Biotechnol       Date:  2010-01-14

7.  Noncollagenous proteins in normal and pathological human bone.

Authors:  K J Quelch; W G Cole; R A Melick
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

8.  Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study.

Authors:  Joachim H Ix; Christina L Wassel; Douglas C Bauer; Damon Toroian; Frances A Tylavsky; Jane A Cauley; Tamara B Harris; Paul A Price; Steven R Cummings; Michael G Shlipak
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

9.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

10.  The relationship between serum and urinary Fetuin-A levels and kidney stone formation among kidney stone patients.

Authors:  Abdolrasoul Mehrsai; Fateme Guitynavard; Mohammad Reza Nikoobakht; Shahram Gooran; Ayat Ahmadi
Journal:  Cent European J Urol       Date:  2017-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.